Mario Cazzola Selected Research

Chronic Obstructive Pulmonary Disease (COPD)

10/2008	Use of 6-min and 12-min walking test for assessing the efficacy of formoterol in COPD.
06/2008	Tiotropium and salmeterol/fluticasone combination do not cause oxygen desaturation in COPD.
08/2007	Tiotropium is less likely to induce oxygen desaturation in stable COPD patients compared to long-acting beta2-agonists.
05/2007	The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: a pilot study.
01/2007	A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD.
11/2006	Effect of formoterol, tiotropium, and their combination in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study.
01/2006	Single inhaler budesonide/formoterol in exacerbations of chronic obstructive pulmonary disease.
01/2006	Additional clinical benefit of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combination.
01/2006	The role of combination therapy with corticosteroids and long-acting beta2-agonists in the prevention of exacerbations in COPD.
06/2005	Treatment of acute exacerbation of severe-to-very severe COPD with azithromycin in patients vaccinated against Streptococcus pneumoniae.
05/2005	Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients.
07/2004	Inhaled combination therapy with long-acting beta 2-agonists and corticosteroids in stable COPD.
03/2004	Comparative effects of a two-week treatment with nebivolol and nifedipine in hypertensive patients suffering from COPD.
01/2004	Salmeterol/fluticasone propionate in a Single Inhaler Device versus theophylline+fluticasone propionate in patients with COPD.
01/2004	The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD.
01/2004	Long-acting bronchodilators are the first-choice option for the treatment of stable COPD.
01/2003	Bronchodilator response to formoterol Turbuhaler in patients with COPD under regular treatment with formoterol Turbuhaler.

Articles by Research Topic

Disease

17	Chronic Obstructive Pulmonary Disease (COPD) 10/2008 - 01/2003
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2008 - 07/2005
3	Asthma (Bronchial Asthma) 02/2006 - 09/2004
3	Iron Overload 07/2003 - 02/2002
2	Cataract (Cataracts) 02/2006 - 03/2002
2	Syndrome 02/2006 - 03/2002
2	Chronic Bronchitis 01/2006 - 10/2005
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 10/2008
1	Refractory Anemia 01/2008
1	Airway Obstruction (Choking) 01/2006
1	Heart Failure 11/2005
1	Neuroblastoma 11/2004
1	Polycythemia Vera 10/2004
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 09/2004
1	Essential Thrombocythemia 08/2004
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2004
1	Hemochromatosis (Bronze Diabetes) 03/2004
1	Anemia 01/2004
1	Respiratory Tract Infections (Respiratory Tract Infection) 07/2003
1	Sideroblastic Anemia 03/2003
1	Thrombosis (Thrombus) 03/2002

Drug/Important Bio-Agent (IBA)

7	IronIBA 10/2008 - 02/2002
7	formoterol (Oxis)FDA Link 10/2008 - 01/2003
7	tiotropium (Spiriva)FDA Link 06/2008 - 01/2004
5	salmeterol (Serevent)FDA Link 06/2008 - 01/2004
4	ErythropoietinIBA 07/2008 - 01/2004
4	fluticasone (Cutivate)FDA LinkGeneric 06/2008 - 01/2004
2	hepcidinIBA 10/2008 - 03/2004
2	OxygenIBA 06/2008 - 08/2007
2	Theophylline (Theon)FDA LinkGeneric 05/2007 - 01/2005
2	Bronchodilator Agents (Bronchodilators)IBA 01/2006 - 01/2004
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2006 - 07/2004
2	Pipobroman (Vercyte)FDA Link 08/2004 - 03/2002
2	metal transporting protein 1 (ferroportin)IBA 07/2003 - 11/2002
1	Serine Endopeptidases (Serine Protease)IBA 10/2008
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2008
1	Matrix MetalloproteinasesIBA 03/2008
1	deferasirox FDA Link 02/2008
1	InterferonsIBA 07/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2006
1	DNA (Deoxyribonucleic Acid)IBA 02/2006
1	prulifloxacinIBA 01/2006
1	Budesonide (Pulmicort)FDA LinkGeneric 01/2006
1	Enoxaparin (Lovenox)FDA Link 01/2006
1	Ofloxacin (Levofloxacin)FDA LinkGeneric 10/2005
1	Azithromycin (Zithromax)FDA LinkGeneric 06/2005
1	omalizumab (Xolair)FDA Link 09/2004
1	Messenger RNA (mRNA)IBA 09/2004
1	anti-IgEIBA 09/2004
1	Codon (Codons)IBA 07/2004
1	nebivolol FDA Link 03/2004
1	Nifedipine (Adalat)FDA LinkGeneric 03/2004
1	QuinolonesIBA 07/2003
1	Ferritins (Ferritin)IBA 03/2003
1	ApoferritinsIBA 03/2002
1	Proteins (Proteins, Gene)IBA 02/2002

Therapy/Procedure

2	Nebulizers and Vaporizers (Inhaler) 01/2006 - 01/2004
1	Blood Transfusion (Blood Transfusions) 11/2004